Human Antibodies With Anti-Lymphocyte Specificities - Licensing Availability

Fri, 03 Apr 2026 11:38:27 +0000
Healthcare

NIH/NIAID issued a notice announcing availability for licensing of novel human IgM antibodies (HHS Ref No. E-025-2025) developed for treating B-cell cancers and autoimmune conditions. The antibodies demonstrated effective B-cell killing at concentrations as low as 0.01 nanomolar. Inventors Dr. Ainhoa Pérez-Díez and Dr. Irini Sereti developed this technology. Companies may contact Benjamin Hurley at 240-276-5489 to pursue licensing.